Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cupric chloride

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cupric chloride in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(cupric chloride)
Trials
(cupric chloride)
Recent Studies (post-2010) (cupric chloride)
9,1561875526875247

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bar-Or, D; Curtis, CG; Rael, LT; Shimonkevitz, RP; Thomas, GW; Winkler, JV; Yukl, RL1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cupric chloride

ArticleYear
Copper stimulates the synthesis and release of interleukin-8 in human endothelial cells: a possible early role in systemic inflammatory responses.
    Shock (Augusta, Ga.), 2003, Volume: 20, Issue:2

    Topics: Cells, Cultured; Copper; Culture Media; Cytokines; Dose-Response Relationship, Drug; Eicosanoids; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Humans; Inflammation; Interleukin-1; Interleukin-8; Oligopeptides; Peptides; Platelet Activating Factor; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transcriptional Activation; Tumor Necrosis Factor-alpha; Umbilical Veins

2003